Bhaskar Anand - 08 Oct 2026 Form 4 Insider Report for Summit Therapeutics Inc. (SMMT)

Reporting relationship: Chief Accounting Officer
Issuer ticker: SMMT
Reported as of: 08 Oct 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 14 Oct 2026, 16:07:18 UTC
Prior SEC filing: 12 Jan 2026
Source filing: View source filing
Reporting owner signature: /s/ Bhaskar Anand

Filing notes and source

Key filing fact

Bhaskar Anand filed Form 4 for Summit Therapeutics Inc. (SMMT) on 14 Oct 2026.

Key facts

This page summarizes Bhaskar Anand's Form 4 filing for Summit Therapeutics Inc. (SMMT).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 14 Oct 2026, 16:07.

Change

Previous filing in this sequence was filed on 12 Jan 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001890784 Primary reporting owner

Anand Bhaskar

Relationship: Chief Accounting Officer
Address: C/O SUMMIT THERAPEUTICS INC., 601 BRICKELL KEY DRIVE, SUITE 1000, MIAMI
Signature: /s/ Bhaskar Anand
Signature date: 14 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SMMT transaction

Common Stock

Award

Transaction value
Shares: +100,000
Change %: +62%
Price: $0.000000^*
Shares after: 261,047
Date: 08 Oct 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Restricted stock units granted under the Issuer's Amended and Restated 2020 Stock Incentive Plan. The restricted stock units vest on October 8, 2029, subject to the Reporting Person continuing his employment with the Issuer, and will entitle the Reporting Person to one share of the Issuer's common stock for each restricted stock unit that vests.

Footnote F2

Holdings include shares previously acquired through exempt transactions pursuant to the Issuer's employee stock purchase plan.